Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia

Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia

Soon Hin How,1,2 Chong Kin Liam,3 Muhammad Adil Zainal Abidin,1 Harissa H Hasbullah,4,5 Lye Mun Tho,6 Gwo Fuang Ho,7 Ibtisam Muhamad Nor,5 Yong Kek Pang,3 Kean Fatt Ho,8 Muthukkumaran Thiagarajan,5 Roziana Ariffin,9 Azlina Samsudin,10 Azza Omar,11 Sin Nee Tan,2 Choo Khoon Ong,12 Sing Yang Soon,13 Ma...

Full description

Bibliographic Details
Main Authors: How SH, Liam CK, Zainal Abidin MA, Hasbullah HH, Tho LM, Ho GF, Muhamad Nor I, Pang YK, Ho KF, Thiagarajan M, Ariffin R, Samsudin A, Omar A, Tan SN, Ong CK, Soon SY, Poh ME
Format: Article
Language:English
Published: Dove Medical Press 2022-06-01
Series:Cancer Management and Research
Subjects:
tyrosine kinase inhibitors
lung cancer
time on treatment
overall survival  
Online Access:https://www.dovepress.com/outcomes-of-patients-with-egfr-mutant-advanced-nsclc-in-a-developing-c-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/outcomes-of-patients-with-egfr-mutant-advanced-nsclc-in-a-developing-c-peer-reviewed-fulltext-article-CMAR

Similar Items